Contact this trialFirst, we need to learn more about you.
Radiopharmaceutical
Lu-DOTA-TATE for Neuroendocrine Cancer
Recruiting1 awardPhase 2
London, Ontario
This trial will test whether Lutetium-177 octreotate can help control symptoms, stabilize disease, and improve quality of life for patients with a certain type of tumor. The study will also measure the safety and overall survival of patients treated with Lutetium-177 octreotate.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service